NewsRx

Search our medical news database

Thoratec Corp.

Thoratec completes enrollment in Bridge-to-Transplantation arm of HeartMate II trial

Published in Physician Law Weekly, June 28th, 2006

Thoratec Corp. (THOR), a world leader in products to treat cardiovascular disease, said that it has completed enrollment in the Bridge-to-Transplantation (BTT) arm of its HeartMate II Pivotal trial by implanting 133 patients.

"This marks an important milestone in our HeartMate II program, as we have now enrolled the number of patients called for in the original trial design and we achieved this goal within 15 months of the trial's initiation. We continue to be encouraged by the positive patient experience in the trial as reported in recent data presentations at leading professional medical meetings," said Gary F. Burbach, president and chief executive officer of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook